Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Plasma Neutrophil Gelatinase-Associated Lipocalin Is Primarily Related to Inflammation during Sepsis: A Translational Approach

  • Gordon P. Otto ,

    gordonpotto@googlemail.com

    Affiliations Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany, Clinic for Anesthesiology and Intensive Care, Jena University Hospital, Jena, Germany

  • Jorge Hurtado-Oliveros,

    Affiliation Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany

  • Ha-Yeun Chung,

    Affiliation Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany

  • Kristin Knoll,

    Affiliation Clinic for Internal Medicine (KIM III)—Rheumatology, Jena University Hospital, Jena, Germany

  • Thomas Neumann,

    Affiliation Clinic for Internal Medicine (KIM III)—Rheumatology, Jena University Hospital, Jena, Germany

  • Hans J. Müller,

    Affiliation Department of Sports Medicine and Health Promotion, Friedrich-Schiller-University, Jena, Germany

  • Marco Herbsleb,

    Affiliation Department of Sports Medicine and Health Promotion, Friedrich-Schiller-University, Jena, Germany

  • Matthias Kohl,

    Affiliation Department of Medical and Life Sciences, Furtwangen University, Villingen-Schwenningen, Germany

  • Martin Busch,

    Affiliation Clinic for Internal Medicine (KIM III)—Nephrology, Jena University Hospital, Jena, Germany

  • Maik Sossdorf,

    Affiliations Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany, Clinic for Anesthesiology and Intensive Care, Jena University Hospital, Jena, Germany

  • Ralf A. Claus

    Affiliations Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany, Clinic for Anesthesiology and Intensive Care, Jena University Hospital, Jena, Germany

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.